These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11229464)

  • 1. Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient.
    Ito S; Nakazono K; Murasawa A; Mita Y; Hata K; Saito N; Kikuchi M; Yoshida K; Nakano M; Gejyo F
    Arthritis Rheum; 2001 Feb; 44(2):339-42. PubMed ID: 11229464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
    Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
    J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of precore-mutant hepatitis B virus genome in patients with acute and fulminant hepatitis using mutation site-specific assay (MSSA).
    Shiraki K; Hamada M; Sugimoto K; Ito T; Yamanaka T; Wagayama H; Shimizu A; Makino Y; Takase K; Nakano T; Tameda Y
    Hepatogastroenterology; 2002; 49(47):1352-6. PubMed ID: 12239941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
    Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.
    Shin JW; Chung YH; Choi MH; Kim JA; Ryu SH; Jang MK; Kim IS; Park NH; Lee HC; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):844-9. PubMed ID: 15946130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis.
    Liu CJ; Kao JH; Lai MY; Chen PJ; Chen DS
    J Med Virol; 2004 Apr; 72(4):545-50. PubMed ID: 14981756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The percentage of hepatitis B virus precore A83 mutant and its dynamicchange in fulminant hepatitis B].
    Tian Q; Guo S; Tan F
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):96-8. PubMed ID: 10861115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of precore variant hepatitis B virus in a child with severe aplastic anaemia.
    Smith PR; Zampino R; Gutteridge C; Karayiannis P; Aitken C
    J Med Virol; 2001 Nov; 65(3):470-2. PubMed ID: 11596080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
    Ozasa A; Tanaka Y; Orito E; Sugiyama M; Kang JH; Hige S; Kuramitsu T; Suzuki K; Tanaka E; Okada S; Tokita H; Asahina Y; Inoue K; Kakumu S; Okanoue T; Murawaki Y; Hino K; Onji M; Yatsuhashi H; Sakugawa H; Miyakawa Y; Ueda R; Mizokami M
    Hepatology; 2006 Aug; 44(2):326-34. PubMed ID: 16871568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.
    Chan HL; Tsang SW; Liew CT; Tse CH; Wong ML; Ching JY; Leung NW; Tam JS; Sung JJ
    Am J Gastroenterol; 2002 Feb; 97(2):406-12. PubMed ID: 11866280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
    Kitano K; Kobayashi H; Hanamura M; Furuta K; Ueno M; Rokuhara A; Tanaka E; Umemura T; Kiyosawa K
    Eur J Haematol; 2006 Sep; 77(3):255-8. PubMed ID: 16923112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel accurate amplification created restriction site method for determination of the wild type and the precore mutant hepatitis B virus variants.
    Amini-Bavil-Olyaee S; Sarrami-Forooshani R; Adeli A; Mahboudi F; Sabahi F; Nafisi H; Zali MR; Azizi M
    J Virol Methods; 2005 Jul; 127(1):19-23. PubMed ID: 15893561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
    Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
    J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic mutations of precore region of hepatitis B virus in hepatitis B e antigen-negative patients with fulminant hepatitis B and translation of precore variants in vitro.
    Guo Y; Hou J; Luo K; Feng X
    Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):42-4. PubMed ID: 11242136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
    Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis.
    Hagiyama H; Kubota T; Komano Y; Kurosaki M; Watanabe M; Miyasaka N
    Clin Exp Rheumatol; 2004; 22(3):375-6. PubMed ID: 15144137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.